Rationally designed drug combination screen in more physiologically relevant in vitro organoid models : can we improve personalized therapy for pancreatic cancer?

Bron
Antwerp, University of Antwerp, Faculty of Medicine and Health Sciences,186 p.

Highlights in gastro-intestinal cancer

Bron
Belgian journal of medical oncology - ISSN 1784-7141-12 (2018) p. 182-188
Auteur(s)

The MATTERS trial : safety and tolerability of whole-body hyperthermia at 41.50°C in combination with chemotherapy in metastatic cancer patients

Bron
Cancer research communications - ISSN 2767-9764-6:2 (2026) p. 273-283
Auteur(s)